NNC0487-0111 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2022
How each study uses NNC0487-0111 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- NNC0487-0111 A
- 3
Studies by the year they started
5 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses NNC0487-0111 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT06542874Written as NNC0487-0111 subcutanous
- A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.CompletedPhase 1Novo Nordisk A/SNCT07121153Written as NNC0487-0111 A
- A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT06478563Written as NNC0487-0111 (formulation D)
- A Research Study on How NNC0487-0111 Works in People With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT05369390Written as NNC0487-0111 A
- A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become PregnantCompletedPhase 1Novo Nordisk A/SNCT06461039Written as NNC0487-0111 A